Organization and Description of Business (Details Narrative)

v3.24.3

Organization and Description of Business (Details Narrative)													3 Months Ended				9 Months Ended
	Jul. 25, 2024 USD ($) shares	Jul. 17, 2024 USD ($)	Jun. 14, 2024 USD ($)	May 20, 2024 $ / shares shares	May 14, 2024 USD ($)	Apr. 05, 2024 USD ($) $ / shares	Mar. 31, 2024 USD ($)	Feb. 23, 2024	Feb. 14, 2024 shares	Feb. 13, 2024 shares	Nov. 13, 2023 USD ($)	Feb. 21, 2023 USD ($) $ / shares shares	Sep. 30, 2024 USD ($) $ / shares shares	Jun. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Mar. 31, 2023 USD ($) shares	Sep. 30, 2024 USD ($) $ / shares shares	Sep. 30, 2023 USD ($)	Jul. 24, 2024 $ / shares shares	Jun. 17, 2024 shares	Mar. 04, 2024 $ / shares	Dec. 31, 2023 USD ($) $ / shares shares	Feb. 28, 2023 $ / shares shares
Common stock, par value | $ / shares													$ 0.001				$ 0.001		$ 0.001		$ 0.001	$ 0.001
Reverse Stock Split								1-for-30	1-for-30
Common stock issued | shares									16,666,666	500,000,000
Common stock, shares authorized | shares									66,666,666	550,000,000			250,000,000				250,000,000					250,000,000
Preferred stock, par value | $ / shares													$ 0.001				$ 0.001					$ 0.001
Issuance of preferred shares		$ 5,100,000
Preferred stock dividends													$ 393,937		$ 391,548		$ 1,375,889	$ 923,677
Derivative fair value												$ 3,149,800	0				0
Stock issuance costs																314,311
Fair value of the warrants																$ 10,623,000
Change in fair value of derivative liability													$ (356,000)		2,566,900		$ (367,000)	2,251,700
Probability of default													7.4				7.4
Fair value of the warrants																		10,623,000
Issuance of warrants																	762,834
Warrants at fair value													$ 17,000		(5,356,000)		4,410,000	(8,166,000)
Change in fair value of derivatives													356,000		(2,566,900)		367,000	(2,251,700)
Derivative Liability, Current													$ 1,282,000				$ 1,282,000					$ 61,000
Preferred Stock, Shares Authorized | shares													50,000,000				50,000,000					50,000,000
Employment agreement description											Effective November 13, 2023, the Company entered into an amendment to the employment agreement of Dr. Chris Chapman, its President and Chief Medical Officer, providing for Dr. Chapman’s annual base salary to be adjusted from five hundred thousand dollars ($500,000) (the “Full Base Salary”) to two hundred fifty thousand dollars ($250,000) in cash per annum, until payment of his Full Base Salary would no longer jeopardize the Company’s ability to continue as a going concern, as determined by the Company in its sole discretion. The amendment further provides that the remaining $250,000 of base salary per annum (the “Deferral Amount”) shall be deferred until payment of the Deferral Amount would no longer jeopardize the Company’s ability to continue as a going concern, as determined by the Company in its sole discretion, at which time the Deferral Amount may be paid, at Dr. Chapman’s election, in shares of Common Stock or in cash. As of September 30, 2024 and December 31, 2023, the Company had recognized a salary deferral of $149,038 and $28,846, respectively, which was paid to Dr. Chapman on June 27, 2024.
Officers compensation																	$ 410,810	769,657
Implementation of directors agreement description											In connection with an overall reduction in compensation paid to the Company’s directors implemented in November 2023, effective November 13, 2023, the Company entered into an amendment to the employment agreement of Christopher C. Schreiber, a Director and the Company’s former Executive Chairman, providing for Mr. Schreiber’s annual fee to be adjusted from three hundred thousand dollars ($300,000) (the “Full Fee”) to sixty thousand dollars ($60,000) in cash per annum, until payment of his Full Fee would no longer jeopardize the Company’s ability to continue as a going concern, as determined by the Company in its sole discretion. The amendment further provides that the remaining $240,000 of the fees per annum (the “Fee Deferral Amount”) shall be deferred until payment of the Fee Deferral Amount would no longer jeopardize the Company’s ability to continue as a going concern, as determined by the Company in its sole discretion, at which time the Fee Deferral Amount may be paid, at Mr. Schreiber’s election, in shares of Common Stock or in cash. The amendment also clarified that Mr. Schreiber’s title is “Director.” As of September 30, 2024 and December 31, 2023, the Company had recognized a salary deferral of $175,385 and $27,692, respectively, which was paid to Mr. Schreiber on August 22, 2024.
Deferred Compensation Payable [Member]
Board fee deferral													$ 209,800				$ 209,800					$ 44,000
Series F-1 Short Term Warrants [Member]
Warrant exercise price | $ / shares													$ 1.816				$ 1.816
Warrants to purchase common stock | shares													2,780,839				2,780,839
Series F-1 Long Term Warrants [Member]
Warrant exercise price | $ / shares													$ 1.816				$ 1.816
Warrants to purchase common stock | shares													2,780,839				2,780,839
Warrants at fair value	$ 6,965,000
Fair value																	$ 968,000
Change in fair value as a non-cash loss	6,000
Series G Short Term Warrants [Member]
Warrants at fair value	12,343,000
Fair value																	1,716,000
Change in fair value as a non-cash loss	$ 11,000
Fair Value, Recurring [Member]
Fair value of the warrants																	21,992,000
Change in fair value of derivative liability																	367,000
Warrants at fair value																	4,410,000
Reclassification of warrant liability to equit upon warrant modification																	(27,269,000)
Change in fair value of derivatives																	(367,000)
Derivative Liability, Current													$ 1,282,000				1,282,000					$ 61,000
Other Operating Income (Expense) [Member]
Change in fair value of derivative liability													$ 0		2,566,900		$ 61,000	2,251,700
Fair value of common stock on valuation date | $ / shares													$ 1.62				$ 1.62
Change in fair value of derivatives													$ 0		(2,566,900)		$ (61,000)	(2,251,700)
Common Stock [Member]
Common stock issued | shares																65,960
Issuance of preferred shares
Exercise price | $ / shares													$ 1.62				$ 1.62					$ 7.77
Preferred Stock [Member]
Issuance of preferred shares																14,087,111
Derivative fair value																3,149,800
Contra Preferred Stock [Member]
Issuance of preferred shares		9,000,000.0
Measurement Input, Expected Dividend Rate [Member]
Derivative measurement input												10.0	10.0				10.0
Estimated equity volatility																	80.00%
Discounted market interest rate																	12.50%
Penalty dividend rate													15.0				15.0
Measurement Input, Exercise Price [Member] | Common Stock [Member]
Exercise price | $ / shares												$ 1.90	$ 1.62				$ 1.62
Measurement Input, Option Volatility [Member]
Derivative measurement input												120.0
Measurement Input, Price Volatility [Member]
Derivative measurement input												190.0
Measurement Input, Maturity [Member]
Time of maturity												1 year 4 months 6 days
Measurement Input, Maturity [Member] | Other Operating Income (Expense) [Member]
Time of maturity																	3 months
Measurement Input, Discount Rate [Member]
Derivative measurement input												6.8
Measurement Input, Lapse Rate [Member]
Derivative measurement input												15.0
Measurement Input, Default Rate [Member]
Derivative measurement input												0.5
Measurement Input Volume Volatility [Member]
Estimated traded volume volatility													330.0				330.0
Series F Convertible Preferred Stock [Member]
Conversion price | $ / shares												$ 2.255
Share issued price, per share | $ / shares						$ 6.765
Issuance of preferred shares						$ 3,000,000
Preferred shares dividend rate												10.00%
Preferred stock conversion ratio percentage													19.99				19.99
Series F Convertible Preferred Stock [Member] | Preferred Stock [Member]
Issuance of preferred shares																912,889
Series F Convertible Preferred Stock [Member] | Measurement Input, Expected Dividend Rate [Member]
Preferred shares dividend rate												15.00%
Series F-1 Preferred Stock [Member]
Warrant exercise price | $ / shares													$ 1.816				$ 1.816
Debt description																	The amortization payments due upon such redemption are payable, at the Company’s election, in cash, or subject to certain limitations, in shares of Common Stock valued at the lower of (i) the Series F Conversion Price then in effect and (ii) the greater of (A) 80% of the average of the three lowest closing prices of the Company’s Series F Common Stock during the thirty trading day period immediately prior to the date the amortization payment is due or (B) a “Floor Price” of $6.60 on a post-split basis (subject to adjustment for stock splits, stock dividends, stock combinations, recapitalizations or other similar events) or, in any case, such lower amount as permitted, from time to time, by the Nasdaq Stock Market.
Preferred shares dividend rate																	10.00%
Preferred stock dividends													$ 421,102		0		$ 488,541	0
Change in fair value of derivative liability													356,000		0		(367,000)	0
Warrants at fair value																	$ 7,900,000
Stock Issued During Period, Shares, Other | shares																	9.3
Derivative liability													900,000				$ 900,000
Proceeds from Issuance of Preferred Stock and Preference Stock																	1,282,000
Fair value													356,000				428,000
Stock discount																	$ 5,100,000
Preferred stock stock description																	(i) approximately $4.2 million related to the difference between the gross proceeds and the allocated residual fair value of the Series F-1 Preferred Stock (i.e., $0), and (ii) approximately $0.9 million related to the stock derivative at issuance, is accounted for as a reduction to the carrying value of the Series F Preferred Stock and will be accreted from the issuance date to maturity in accordance with ASC 480-10-S99-3A as redemption is deemed probable pursuant to the Installment Redemption terms of the Series F-1 Certificate of Designations.
Change in fair value of derivatives													(356,000)		0		$ 367,000	0
Derivative Liability, Current													$ 1,282,000				$ 1,282,000
Series F-1 Preferred Stock [Member] | Measurement Input, Expected Dividend Rate [Member]
Preferred shares dividend rate																	15.00%
Derivative measurement input													10.0				10.0
Series F-1 Preferred Stock [Member] | Measurement Input, Option Volatility [Member]
Derivative measurement input													100.0				100.0
Series F-1 Preferred Stock [Member] | Measurement Input, Price Volatility [Member]
Derivative measurement input													275.0				275.0
Series F-1 Preferred Stock [Member] | Measurement Input, Maturity [Member]
Time of maturity																	9 months
Series F-1 Preferred Stock [Member] | Measurement Input, Discount Rate [Member]
Derivative measurement input													4.18				4.18
Series F-1 Preferred Stock [Member] | Measurement Input, Lapse Rate [Member]
Derivative measurement input													15.0				15.0
Series F-1 Preferred Stock [Member] | Measurement Input, Default Rate [Member]
Derivative measurement input													5.2				5.2
Series G Preferred Stock [Member]
Preferred shares dividend rate																	10.00%
Preferred stock dividends													$ 288,068		0		$ 325,213	0
Series G Preferred Stock [Member] | Preferred Stock [Member]
Warrants at fair value		14,100,000
Proceeds from Issuance of Preferred Stock and Preference Stock		$ 22,300,000
Series G Preferred Stock [Member] | Measurement Input, Expected Dividend Rate [Member]
Preferred shares dividend rate																	15.00%
Series F Common Stock Warrants [Member]
Fair value of the warrants																$ 10,623,000
Series F Common Stock Warrants [Member] | Warrant [Member]
Warrants term																5 years
Series F Common Stock Warrants [Member] | Measurement Input, Option Volatility [Member]
Stock price per share																125.0
Series F Common Stock Warrants [Member] | Measurement Input, Expected Dividend Payment [Member]
Stock price per share																0
Series F Common Stock Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member]
Stock price per share																4.09
Series F Warrants [Member]
Fair value of the warrants																	$ 7,961,000
Series F Warrants [Member] | Fair Value, Recurring [Member]
Warrant liability					$ 7,961,000		$ 7,094,000
Reclassification of warrant liability to equit upon warrant modification							$ 7,961,000
Series F Warrants [Member] | Other Operating Income (Expense) [Member]
Warrants at fair value															$ 0		$ 7,094,000	$ 8,166,000
Series F Warrants [Member] | Warrant [Member]
Warrants term													3 years 10 months 24 days				3 years 10 months 24 days
Series F Warrants [Member] | Measurement Input, Option Volatility [Member]
Stock price per share													110.0				110.0
Series F Warrants [Member] | Measurement Input, Expected Dividend Payment [Member]
Stock price per share													0				0
Series F Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member]
Stock price per share													4.31				4.31
Series F One Preferreds Stock [Member]
Debt description																	The amortization payments due upon such redemption are payable, at the Company’s election, in cash at 105% of the applicable Installment Redemption Amount (as defined in the Series F-1 Certificate of Designations), or subject to certain limitations, in shares of Common Stock valued at the lower of (i) the Series F-1 Conversion Price then in effect and (ii) the greater of (A) 80% of the average of the three lowest closing prices of the Company’s Common Stock during the thirty consecutive trading day period ending and including the trading day immediately prior to the date the amortization payment is due or (B) $0.364, which is 20% of the “Minimum Price” (as defined in Nasdaq Stock Market Rule 5635) on the date in which the Series F-1 Stockholder Approval (as defined herein) was obtained or, in any case, such lower amount as permitted, from time to time, by the Nasdaq Capital Market, and, in each case, subject to adjustment for stock splits, stock dividends, stock combinations, recapitalizations or other similar events, which amortization amounts are subject to certain adjustments as set forth in the Series F-1 Certificate of Designations (the “Series F-1 Floor Price”).
Series G Convertible Preferred Stock [Member] | Preferred Stock [Member]
Issuance of preferred shares
Investors [Member] | Warrant [Member] | Series G Short Term Warrants [Member]
Warrants to purchase common stock | shares													4,928,416				4,928,416
Investors [Member] | Warrant [Member] | Series G Warrants [Member]
Warrant exercise price | $ / shares													$ 1.816				$ 1.816
Warrants to purchase common stock | shares													4,928,416				4,928,416
Director [Member]
Deferral excess payment											$ 156,000
Eagle Uzonwanne [Member]
Deferral excess payment											36,000
Securities Purchase Agreement [Member]
shares issued | shares				5,050
Issuance of warrants | shares				2,780,839
Warrant exercise price | $ / shares				$ 1.816
Preferred stock, stated value | $ / shares				$ 1,000
Securities Purchase Agreement [Member] | Series F-1 Short Term Warrants [Member]
Issuance of warrants | shares				2,780,839
Warrant exercise price | $ / shares				$ 1.816
Securities Purchase Agreement [Member] | Series F-1 Long Term Warrants [Member]
Issuance of warrants | shares				2,780,839
Warrant exercise price | $ / shares				$ 1.816
Securities Purchase Agreement [Member] | Series F-1 Preferred Stock [Member]
Preferred stock, par value | $ / shares				0.001
Securities Purchase Agreement [Member] | Series G Preferred Stock [Member]
Preferred stock, par value | $ / shares				$ 0.001
Securities Purchase Agreement [Member] | Investors [Member]
shares issued | shares												15,000
Preferred stock stated value												$ 1,000
Issuance of warrants | shares												6,651,885
Warrant exercise price | $ / shares												$ 2.255											$ 3.18
Issuance of warrants												$ 6,651,885
Preferred stock, par value | $ / shares												$ 3.18
Warrant exercise price | $ / shares												$ 3.18
Warrants to purchase common stock | shares												4,716,904											4,716,904
Convertible shares issuable | shares												8,259,911											8,259,911
Conversion price | $ / shares												$ 1.816
Warrants term																							5 years
Securities Purchase Agreement [Member] | Investors [Member] | Series G Short Term Warrants [Member]
Issuance of warrants | shares				4,928,416
Warrant exercise price | $ / shares				$ 1.816
Securities Purchase Agreement [Member] | Investors [Member] | Series G Long Term Warrants [Member]
Issuance of warrants | shares				4,928,416
Warrant exercise price | $ / shares				$ 1.816
Securities Purchase Agreement [Member] | Investors [Member] | Common Stock [Member]
Warrants to purchase common stock | shares																							4,716,904
Securities Purchase Agreement [Member] | Investors [Member] | Series F Preferred Stock [Member]
Warrant exercise price | $ / shares												1.816
Preferred stock, par value | $ / shares												1.816
Securities Purchase Agreement [Member] | Investors [Member] | Series G Preferred Stock [Member]
shares issued | shares				8,950
Issuance of warrants | shares				4,928,416
Warrant exercise price | $ / shares												1.816
Conversion price | $ / shares													$ 1.816				$ 1.816
Securities Purchase Agreement [Member] | Investors [Member] | Series F Common Stock Warrants [Member]
Warrant exercise price | $ / shares																							$ 1.816
Series G Preferred Stock [Member]
Preferred stock, stated value | $ / shares				$ 1,000
Series F-1 Registration Rights Agreement [Member]
Series F-1 registration rights description																	the Company entered into a Registration Rights Agreement with the Series F-1 Investors (the “Series F-1 Registration Rights Agreement,”), pursuant to which the Company agreed to file a resale registration statement (the “Series F-1 Registration Statement”) with the SEC to register for resale (A) 200% of the Series F-1 Conversion Shares and (B) 200% of the Series F-1 Warrant Shares promptly following the Closing Date, but in no event later than 30 calendar days after the Closing Date, and to have such Series F-1 Registration Statement declared effective by the Effectiveness Deadline (as defined in the Series F-1 Registration Rights Agreement).
Series G Registration Rights Agreement [Member]
Series F-1 registration rights description																	the Company entered into a Registration Rights Agreement with the Series G Investors (the “Series G Registration Rights Agreement” and, together with the Series F-1 Registration Rights Agreement, the “Registration Rights Agreements”) pursuant to which the Company agreed to file a resale registration statement (the “Series G Registration Statement”) with the SEC to register for resale (A) 200% of the Series G Conversion Shares, (B) 200% of the shares of Common Stock issuable upon conversion of the PIK Shares, and (C) 200% of the Series G Warrant Shares promptly following the Closing Date, but in no event later than 30 calendar days after the Closing Date, and to have such Series G Registration Statement declared effective by the Effectiveness Deadline (as defined in the Series G Registration Rights Agreement).
Gpn agreement [Member] | Series F Warrants [Member]
Private Placement Warrants Description																	In connection with the Private Placements, pursuant to (A) an engagement letter (the “GPN Agreement”) with GP Nurmenkari Inc. (“GPN”) and (B) an engagement letter (the “Palladium Agreement,” and collectively with the GPN Agreement, the “Engagement Letters”) with Palladium Capital Group, LLC (“Palladium,” and collectively with GPN, the “Placement Agents”), the Company engaged the Placement Agents to act as non-exclusive placement agents in connection with each Private Placement, pursuant to which, the Company agreed to (i) pay the Placement Agents a cash fee equal to 3% of the gross proceeds of each Private Placement (including any cash proceeds realized by the Company from the exercise of the Series F Warrants), (ii) reimbursement and payment of certain expenses, and (iii) issue to the Placement Agents on the Closing Date, warrants to purchase up to an aggregate of 693,833 of shares of Common Stock to each Placement Agent, which is equal to 3% of the aggregate number of shares of Common Stock underlying the securities issued in each Private Placement, including upon exercise of any Series F Warrants, with terms identical to the Series G Long-Term Warrants and Series F-1 Long-Term Warrants.
Separation Agreement [Member]
Officers compensation			$ 125,000
Payments to officer			$ 25,000
Salaries													$ 0				$ 150,000
Share based compensation													$ 0				$ 197,427
Minimum [Member]
Common stock, shares authorized | shares	16,666,666																		16,666,666
Minimum [Member] | Series F Convertible Preferred Stock [Member]
Conversion price | $ / shares												$ 60.21	$ 60.21				$ 60.21
Minimum [Member] | Series F-1 Preferred Stock [Member]
Conversion price | $ / shares													2.253				2.253
Minimum [Member] | Series G Preferred Stock [Member]
Common stock, shares authorized | shares																				8,950
Conversion price | $ / shares													$ 2.253				$ 2.253
Minimum [Member] | Director [Member]
Director fees											60,000
Minimum [Member] | Eagle Uzonwanne [Member]
Director fees											60,000
Minimum [Member] | Amendment Agreement [Member] | Series G Convertible Preferred Stock [Member]
Preferred Stock, Shares Authorized | shares																				8,950
Maximum [Member]
Common stock, shares authorized | shares									250,000,000										250,000,000
Maximum [Member] | Common Stock [Member]
Preferred stock conversion ratio percentage													19.99				19.99
Maximum [Member] | Series G Preferred Stock [Member]
Common stock, shares authorized | shares																				12,826,273
Maximum [Member] | Director [Member]
Director fees											216,000
Maximum [Member] | Eagle Uzonwanne [Member]
Director fees											$ 96,000
Maximum [Member] | Amendment Agreement [Member] | Series G Convertible Preferred Stock [Member]
Preferred Stock, Shares Authorized | shares																				12,826,273